Ranibizumab for Macular Edema Secondary to Central and Branch Retinal Vein Occlusion in Patients Younger Than 50 Years of Age

BACKGROUND: To determine the effectiveness of intravitreal ranibizumab (IVR) approach over 1-year follow-up in patients younger than 50 years old with central and branch retinal vein occlusion (RVO) complicated by macular edema (ME). METHODS: Prospective, open-label case series. Patients initiating...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Biomed Res Int
Главные авторы: Battaglia Parodi, Maurizio, Romano, Francesco, Arrigo, Alessandro, Mercuri, Stefano, Franceschi, Alessandro, Bandello, Francesco
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi 2020
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7320288/
https://ncbi.nlm.nih.gov/pubmed/32685489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/4747696
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы